NCT00020267View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2000

Conditions

Lung CancerAdult Soft Tissue SarcomaColorectal CancerBone CancerOvarian SarcomaMelanomaColon CancerRectal CancerBreast CancerEye CancerUterine Sarcoma

Interventions

DRUG

interleukin-2

DRUG

MAGE-12 peptide vaccine

DRUG

Montanide ISA-51

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00020267 - Vaccine Therapy in Treating Patients With Metastatic Cancer | Biotech Hunter | Biotech Hunter